Reducing the Acute Care Burden of Childhood Asthma on Health Services in British Columbia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01326494|
Recruitment Status : Active, not recruiting
First Posted : March 31, 2011
Last Update Posted : April 16, 2019
|Condition or disease||Intervention/treatment||Phase|
|Upper Respiratory Tract Infection Asthma||Drug: Arm 1 Oral Cortico Steroids||Phase 4|
In Canada, asthma affects more the 12% of children. Exacerbation are a common feature of asthma. In children, upper respiratory tract infection (URTI's) are responsible for over 80% of asthma exacerbation.
Experts in asthma care acknowledge this critical problem and have developed guidelines to reduce asthma exacerbation.
The criteria for participation in this study to have 2 or more presentations to a Health Service centre in the past 12 months for URTI induced asthma. These patients will be followed and interviewed monthly over a 12 month period to investigate whether the use of Oral cortico-steroids upon early onset of URTI induced asthma prevents the need for presentation to hospital
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||92 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Reducing the Acute Care Burden of Childhood Asthma on Health Services in British Columbia|
|Study Start Date :||April 2011|
|Actual Primary Completion Date :||May 2012|
|Estimated Study Completion Date :||December 2019|
Active Comparator: Arm 1 Oral Cortico Steroid
A filled prescription will be given to be used upon early onset of symptoms.
Drug: Arm 1 Oral Cortico Steroids
Prednisolone: 1 mg / kg per day course of dose for 5 days up to child's weight of 20 kgs.
Dexamethasone: 0.3mg/kg per dose for 3 days (minimum weight 20 kgs )
Other Name: Prednisone
No Intervention: Usual care for Asthma treatment
monitor the readmission of URTI induced asthma in children over a 12 month period
- Reduction of representation to Health Services for Exacerbation of URTI induced asthma [ Time Frame: One year ]To review the effect of medication given at early onset of symptoms have on reducing the presentation to Health Services and Emergency Departments.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01326494
|Canada, British Columbia|
|BC Children's Hospital|
|Vancouver, British Columbia, Canada, V6H 3V4|
|Principal Investigator:||Bruce Carleton, B.Pharm, Pharm.D.||The University of British Columbia|